RELMADA THERAPEUTICS, INC. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure for Q3 2022

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
Relmada Therapeutics, Inc. annual/quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate for Q3 2022.
  • Relmada Therapeutics, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending August 16, 2022 was 0.01 pure.
  • Relmada Therapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
  • Relmada Therapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
  • Relmada Therapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2021 was 0.21 pure, unchanged from 2020.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 0.01 Aug 16, 2022 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.